Lion ChemTech Co Ltd
KOSDAQ:171120
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lion ChemTech Co Ltd
KOSDAQ:171120
|
KR |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
|
CN |
|
V
|
Vizsla Silver Corp
F:0G3
|
CA |
|
OSB Group PLC
LSE:OSB
|
UK |
|
N
|
New Zealand Energy Corp
OTC:NZERF
|
NZ |
|
B
|
Ben Thanh Services JSC
VN:BSC
|
VN |
|
P
|
Passat SA
PAR:ALPAS
|
FR |
|
T
|
Task Group Holdings Ltd
NZX:TSK
|
NZ |
|
IGEA Pharma NV
SIX:IGPH
|
NL |
|
S
|
S Net Systems Inc
KOSDAQ:038680
|
KR |
|
K
|
Kool2play SA
WSE:K2P
|
PL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Lion ChemTech Co Ltd's stock price target?
Not Available
Lion ChemTech Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Lion ChemTech Co Ltd?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 9 years is -1%.
What is the Operating Income forecast for Lion ChemTech Co Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 9 years is 8%.
What is the Pre-Tax Income forecast for Lion ChemTech Co Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 9 years is 8%.
What is the Net Income forecast for Lion ChemTech Co Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 9 years is 9%.